Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

gwpharma

Cannabis-based treatment scores Phase 3 successes for GW Pharma

December 6, 2016 Manufacturing and Production, Research and Development GW Pharma, cannabidiol

UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …
News
jeffrey_eisenberg

Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic

Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …
Appointment

Mission Therapeutics announces new non-executive chairman

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment

Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …
Appointment
hands-coffee-smartphone-technology_smaller

Technology and patient adherence: Putting control of medication directly in patients’ hands

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing apps, patient adherence, technology

Ben Hargreaves looks at how apps and medical devices could reduce these figures by providing patients new ways of keeping …
Feature
reneuron

ReNeuron’s stem cell therapy improves motor function in stroke study

December 5, 2016 Research and Development ReNeuron, stem cell, stem cell therapy, stroke

ReNeuron, a UK-based biotechnology company, posted results of its experimental stem cell therapy for patients who had been disabled after …
News
161201120435_1_900x600

New molecular-binding technique promises accelerated drug development

December 5, 2016 Research and Development, Sales and Marketing Alzheimer's, Cancer, Indiana University-Purdue University Indianapolis

Researchers at the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) have claimed to have designed a new molecular …
News
novartis_building

Novartis posts 82% remission rate in CAR T paediatric study

December 5, 2016 Research and Development, Sales and Marketing CAR T, CAR-T, Novartis, leukaemia, paediatric

Novartis has released the results of its global, paediatric study of the treatment of leukaemia in children and young adults …
News
kitepharma_fullcolor_rgb

Kite Pharma names new senior VP of Supply Chain

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, kite pharma

Santa-Monica-based clinical-stage biopharmaceutical firm Kite Pharma has appointed Dr Jian Irish as senior vice president of Supply Chain, who will …
Appointment
eisai_halaven_eribulin_web

Eisai & Clinigen to bring breast cancer drug to South Africa

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer

Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …
News
ncri-harpal-hero

Cancer Research UK announces “largest ever” development investment

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer Research UK

Cancer Research UK (CRUK) is set to inject a total of £226 million into centres across the UK over the …
News
happy_doctor

Illegal psilocybin shows promise in treatment of depression

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin

A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’,  has been found to have substantial mental …
News
blood-75302_640

Researchers develop capsule-based haemophilia treatment tech

November 30, 2016 Research and Development University of Texas, haemophilia

Researchers at the University of Texas have developed a new method for treating haemophilia B which utilises a biodegradable oral …
News

Teva to shut down Maltese plant, axe 210 jobs

November 30, 2016 Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva

Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …
News
advanced_manufacturing_building_site_uon

£25m flagship manufacturing & research facility for University of Nottingham

November 30, 2016 Manufacturing and Production, Research and Development University of Nottingham

Earlier this month, the University of Nottingham began work on a ‘pioneering’ Advanced Manufacturing Building. The £25 million, 9,011 square-metre …
News
humira_abbott_

Humira biosimilar proves efficacy in Phase 3 trial

November 30, 2016 Research and Development AbbVie, Amgen, FDA, Humira, M923, Momenta

US-based biotechnology firm Momenta Pharmaceuticals has announced that its biosimilar version of Abbvie’s autoimmune drug Humira (adalimumab) – currently the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025